Company / Income Tax
Monopar Therapeutics Income Tax History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$800
FY2025
5-year range
-$3.6K / $800
FY2021-FY2025
Trend
+0.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$800 in FY2025.
Remained stable around $800 over the past 2 years.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, income tax increased 0.0% year-over-year.
- Lowest income tax in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 19.82 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $800 | +0.0% |
| FY2024 | $800 | +0.0% |
| FY2023 | $800 | - |
| FY2019 | $0 | +100.0% |
| FY2018 | -$3.6K | -544.8% |
| FY2017 | $800 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026